The five leading vaccine candidates in late-stage trials will be able to supply 5.9 billion doses, enough to inoculate about three billion people, the Oxfam report said. Some 51% of those jabs have been snapped up by the wealthy world, including the US, Britain, the EU, Australia, Hong Kong and Macau, Japan, Switzerland and Israel.
from Hindustan Times - world https://ift.tt/2FHgUC5
via IFTTT
from Hindustan Times - world https://ift.tt/2FHgUC5
via IFTTT
إرسال تعليق